[1]
A. M. A. Rasool, A. M. S. Rashid, E. H. A. Hassan, and A. Subhi, “REPURPOSING ORLISTAT AS A FATTY ACID SYNTHASE INHIBITOR IN BREAST CANCER: IN VITRO EFFICACY, MECHANISMS, AND SYNERGY WITH DOXORUBICIN”, JMGCB, vol. 3, no. 1, pp. 73–89, Dec. 2025.